NJV
- Product code
- NJV
- Device name
- Test, Albumin Cobalt Binding
- Device class
- Class 2
- 21 CFR
- 21 CFR 862.1215
- Medical specialty
- Clinical Chemistry
- Marketing pathway
- 510(K)
- Flag
- Third-party review eligible
- 510(k) clearances (all years, FDA)
- 2 (all years; only the last 3 years are listed here)
FDA classification definition
The Albumin Cobalt Binding Test is a quantitative in vitro diagnostic test used on human serum that detects Ischemia Modified Albumin by measuring the cobalt binding capacity of albumin in human serum. IMA is intended for use in conjunction with other tests such as ECG and cardiac troponin as an aid to the short term risk stratification of patients presenting with chest pain suggestive of cardiac origin.
Official FDA classification page: NJV
Classification and pathway per current FDA publications. Data from openFDA (CC0).